CoChat

Microalbuminuria in Diabetes: A Population Study of the Prevalence and an Assessment of Three Screening Tests

Gatling, W., Knight, C., Mullee, M. A., Hill, R. D. · 1988 · Diabetic Medicine
Cited by 128

The DOI matches its Crossref record.

Abstract

A single observer reviewed 842 of the 917 known diabetic patients registered with 40 GPs in the Poole area. A midstream urine specimen was tested for proteinuria using Albustix (Ames) and cultured to detect bacterial infection. After the first 3 months of the survey, the aliquot of this specimen was frozen for later determination of the random albumin/creatinine ratio (R‐Alb/Creat). Patients were requested to submit a timed overnight urine collection for estimation of urinary albumin excretion rate (AER). Of the 842 patients reviewed, 493 (59 %) submitted timed overnight urine collections; 43 were excluded because of urinary infection and/or proteinuria. One hundred and thirty‐three (30 %) of 450 diabetic patients were found to have microalbuminuria, although only 31 (7 %) had an AER >30 μg/min. Six hundred and seven urine samples were collected for R‐Alb/Creat but 68 were excluded because of infection and/or proteinuria; in 10 further samples urinary creatinine was not measured. Two hundred and four (38 %) of 532 diabetic patients were found to have an elevated R‐Alb/Creat. There was a significant correlation between AER and R‐Alb/Creat (r=0.32, p<0.001) but a considerable number of patients showed either a normal AER and high R‐Alb/Creat or the reverse. The value of R‐Alb/Creat or an overnight urinary albumin concentration, or an overnight urinary albumin/creatinine ratio (ON‐Alb/Creat) as screening tests to predict AER > 30 μg/min was assessed. An ON‐Alb/Creat > 2.0 mg/mmol was the optimal screening test (sensitivity 96 % and specificity 99.7 %). The proportion of diabetic patients with an AER in the range indicating a high risk of developing nephropathy is small. If an ON‐Alb/Creat > 2 mg/mmol had been used, 84 % of diabetic patients in this survey would not have been identified as being at risk. In future, this will enable further assessment to be concentrated on the high risk group.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.1988.tb01002.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 128

Metadata

Authors
Gatling, W., Knight, C., Mullee, M. A., & Hill, R. D.
Venue
Diabetic Medicine
Publisher
Wiley
Published
1988-05-06
Volume
5
Issue
4
Pages
343-347
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2081175377
Cited by
128
References
0
FWCI
5.31
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Microalbuminuria in Diabetes: A Population Study of the Prevalence and an Assessment of Three Screening Tests. https://app.cochat.ai/papers/10.1111/j.1464-5491.1988.tb01002.x
The paper
Gatling, W., Knight, C., Mullee, M. A., & Hill, R. D. (1988). Microalbuminuria in Diabetes: A Population Study of the Prevalence and an Assessment of Three Screening Tests. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.1988.tb01002.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.